Display options
Cite
Tournaye H, Sukhikh GT, Kahler E, et al. A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization. Hum Reprod. 2017;32(10):2152doi: 10.1093/humrep/dex266.
Tournaye, H., Sukhikh, G. T., Kahler, E., & Griesinger, G. (2017). A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization. Human reproduction (Oxford, England), 32(10), 2152. https://doi.org/10.1093/humrep/dex266
Tournaye, Herman, et al. "A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization." Human reproduction (Oxford, England) vol. 32,10 (2017): 2152. doi: https://doi.org/10.1093/humrep/dex266
Tournaye H, Sukhikh GT, Kahler E, Griesinger G. A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization. Hum Reprod. 2017 Oct 01;32(10):2152. doi: 10.1093/humrep/dex266. PMID: 28938733; PMCID: PMC6790500.
Copy Download .nbib Format: NLM
Share it on

Hum Reprod. 2017 Oct 01;32(10):2152. doi: 10.1093/humrep/dex266.

A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization.

Human reproduction (Oxford, England)

Herman Tournaye, Gennady T Sukhikh, Elke Kahler, Georg Griesinger

Affiliations

  1. Centre for Reproductive Medicine, Universitair Ziekenhuis Brussel (UZ Brussel), Laarbeeklaan 101, 1090 Brussels, Belgium.
  2. Research Centre for Obstetrics, Gynecology and Perinatology, Akademika Oparina Street, 4, 117497, Moscow, Russia.
  3. Clinical Development, Established Pharmaceuticals, Abbott Laboratories GmbH, Freundallee 9A, 30173 Hannover, Germany.
  4. Department of Gynecological Endocrinology and Reproductive Medicine, Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany.

PMID: 28938733 PMCID: PMC6790500 DOI: 10.1093/humrep/dex266

[No abstract available.]

Publication Types